Bloodstream Infections Among Transplant Recipients: Results of a Nationwide Surveillance in Spain 1

Bloodstream infections (BSIs) are a major cause of morbidity and mortality in transplant recipients. The aim of this study is to describe the incidence, microbiology and outcomes of BSIs in transplant recipients in Spain. The Spanish Network for Research on Infection in Transplantation (RESITRA) is formed by 16 centers with transplant program in Spain. The incidence and characteristics of BSIs in transplant patients were obtained prospectively from the cohort. We included 3926 transplant recipients (2935 solid organ and 991 hematopoietic stem cell transplants). Overall, 730 episodes of BSIs were recorded with an incidence rate ranging from 3 episodes per 10 000 transplant days in kidney recipients to 44 episodes per 10 000 transplant days in allogeneic hematopoietic stem cell transplantation (HSCT). The most frequent sources were intravascular catheters and the most frequent microorganisms isolated were coagulase‐negative staphylococci. Crude mortality of BSIs was 7.8%, being highest in liver recipients (16%). Multidrug resistant nonfermentative gram‐negative BSIs had significantly worse prognosis than those caused by their susceptible counterparts (p = 0.015), but no differences were found between resistant and susceptible gram‐negative enteric bacilli, S. aureus or Candida spp. BSIs are still a major concern in transplant recipients. The increasing isolations of multiresistant microorganisms represent a challenge for the next years.

[1]  P. Pronovost,et al.  An intervention to decrease catheter-related bloodstream infections in the ICU. , 2006, The New England journal of medicine.

[2]  J. Aguado,et al.  A Review of Critical Periods for Opportunistic Infection in the New Transplantation Era , 2006, Transplantation.

[3]  M. Falagas,et al.  The diversity of definitions of multidrug-resistant (MDR) and pandrug-resistant (PDR) Acinetobacter baumannii and Pseudomonas aeruginosa. , 2006, Journal of medical microbiology.

[4]  A. Humar,et al.  Bacteremia in Lung Transplant Recipients in the Current Era , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[5]  R. Margreiter,et al.  Infectious complications following 72 consecutive enteric‐drained pancreas transplants , 2006, Transplant international : official journal of the European Society for Organ Transplantation.

[6]  E. Bouza,et al.  Bloodstream Infections among Heart Transplant Recipients , 2006, Transplantation.

[7]  D. Brennan,et al.  The Incidence and Costs of Sepsis and Pneumonia Before and After Renal Transplantation in the United States , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[8]  A. Moreno,et al.  Bacteremia and septic shock after solid-organ transplantation. , 2005, Transplantation proceedings.

[9]  M. Falagas,et al.  Combination Therapy with Intravenous Colistin for Management of Infections Due to Multidrug-Resistant Gram-Negative Bacteria in Patients without Cystic Fibrosis , 2005, Antimicrobial Agents and Chemotherapy.

[10]  P. Muñoz,et al.  Risk factors for invasive aspergillosis in solid-organ transplant recipients: a case-control study. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  Matthew E Falagas,et al.  Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[12]  R. Wenzel,et al.  Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[13]  Nina Singh,et al.  Bacteremias in liver transplant recipients: Shift toward gram‐negative bacteria as predominant pathogens , 2004, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[14]  M. L. de la Mata,et al.  High Mortality Related with Staphylococcus aureus Bacteremia After Liver Transplantation , 2002, European Journal of Clinical Microbiology and Infectious Diseases.

[15]  P. Grossi,et al.  Prevalence and outcome of invasive fungal infections in 1,963 thoracic organ transplant recipients: a multicenter retrospective study. Italian Study Group of Fungal Infections in Thoracic Organ Transplant Recipients. , 2000, Transplantation.

[16]  Nina Singh,et al.  Predicting bacteremia and bacteremic mortality in liver transplant recipients , 2000, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[17]  L. Mermel,et al.  Prevention of intravascular catheter-related infections. , 1994, Annals of internal medicine.

[18]  N. Kneteman,et al.  Comparative Risk of Bloodstream Infection in Organ Transplant Recipients , 1994, Infection Control & Hospital Epidemiology.

[19]  W. Knaus,et al.  Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. , 1992, Chest.

[20]  J. E. Carceller.  American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis , 1992, Critical care medicine.

[21]  B. Yangco,et al.  CDC definitions for nosocomial infections. , 1989, American journal of infection control.

[22]  J M Hughes,et al.  CDC definitions for nosocomial infections, 1988. , 1988, American journal of infection control.

[23]  F. Marco,et al.  Bacterial and fungal bloodstream isolates from 796 hematopoietic stem cell transplant recipients between 1991 and 2000 , 2004, Annals of Hematology.

[24]  J. Bartlett.  Nosocomial bloodstream infections in US hospitals: Analysis of 24,179 cases from a prospective nationwide surveillance study , 2004 .

[25]  T. C. White,et al.  Candidemia in allogeneic blood and marrow transplant recipients: evolution of risk factors after the adoption of prophylactic fluconazole. , 2000, The Journal of infectious diseases.